Phibro Animal Health (PAHC) Revenue & Revenue Breakdown
Phibro Animal Health Revenue Highlights
Latest Revenue (Y)
$977.89M
Latest Revenue (Q)
$263.22M
Main Segment (Y)
Vaccines
Main Geography (Y)
UNITED STATES
Phibro Animal Health Revenue by Period
Phibro Animal Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-06-30 | $977.89M | 3.78% |
| 2022-06-30 | $942.30M | 13.07% |
| 2021-06-30 | $833.40M | 4.12% |
| 2020-06-30 | $800.40M | -3.33% |
| 2019-06-30 | $828.00M | 0.98% |
| 2018-06-30 | $820.00M | 7.29% |
| 2017-06-30 | $764.30M | 1.70% |
| 2016-06-30 | $751.50M | 0.39% |
| 2015-06-30 | $748.59M | 8.19% |
| 2014-06-30 | $691.90M | 5.93% |
| 2013-06-30 | $653.15M | -0.15% |
| 2012-06-30 | $654.10M | 5.78% |
| 2011-06-30 | $618.33M | 4.06% |
| 2010-06-30 | $594.20M | 10.63% |
| 2009-06-30 | $537.10M | 5.03% |
| 2008-06-30 | $511.40M | 12.89% |
| 2007-06-30 | $453.00M | 13.70% |
| 2006-06-30 | $398.40M | 9.33% |
| 2005-06-30 | $364.40M | 2.82% |
| 2004-06-30 | $354.40M | 4.91% |
| 2003-06-30 | $337.80M | 2.77% |
| 2002-06-30 | $328.70M | 2.82% |
| 2001-06-30 | $319.70M | -1.02% |
| 2000-06-30 | $323.00M | - |
Phibro Animal Health generated $977.89M in revenue during NA 2023, up 3.78% compared to the previous quarter, and up 119.25% compared to the same period a year ago.
Phibro Animal Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-03-31 | $263.22M | 5.31% |
| 2023-12-31 | $249.94M | 8.06% |
| 2023-09-30 | $231.30M | -9.31% |
| 2023-06-30 | $255.05M | 3.81% |
| 2023-03-31 | $245.70M | 0.43% |
| 2022-12-31 | $244.65M | 5.21% |
| 2022-09-30 | $232.52M | -8.92% |
| 2022-06-30 | $255.30M | 6.54% |
| 2022-03-31 | $239.62M | 2.97% |
| 2021-12-31 | $232.71M | 8.41% |
| 2021-09-30 | $214.66M | -2.56% |
| 2021-06-30 | $220.30M | 4.05% |
| 2021-03-31 | $211.73M | 2.71% |
| 2020-12-31 | $206.15M | 5.61% |
| 2020-09-30 | $195.19M | 5.00% |
| 2020-06-30 | $185.90M | -11.79% |
| 2020-03-31 | $210.74M | -1.53% |
| 2019-12-31 | $214.01M | 12.80% |
| 2019-09-30 | $189.72M | -6.95% |
| 2019-06-30 | $203.90M | -0.89% |
| 2019-03-31 | $205.74M | -5.72% |
| 2018-12-31 | $218.22M | 9.03% |
| 2018-09-30 | $200.15M | -5.50% |
| 2018-06-30 | $211.80M | 1.38% |
| 2018-03-31 | $208.91M | 1.47% |
| 2017-12-31 | $205.88M | 6.44% |
| 2017-09-30 | $193.41M | -0.71% |
| 2017-06-30 | $194.80M | 2.60% |
| 2017-03-31 | $189.86M | -0.91% |
| 2016-12-31 | $191.60M | 1.92% |
| 2016-09-30 | $187.99M | -0.64% |
| 2016-06-30 | $189.20M | 3.13% |
| 2016-03-31 | $183.46M | -4.33% |
| 2015-12-31 | $191.77M | 2.49% |
| 2015-09-30 | $187.12M | 1.17% |
| 2015-06-30 | $184.95M | -1.36% |
| 2015-03-31 | $187.50M | -0.63% |
| 2014-12-31 | $188.69M | 0.66% |
| 2014-09-30 | $187.46M | 2.06% |
| 2014-06-30 | $183.68M | 6.01% |
| 2014-03-31 | $173.27M | 0.30% |
| 2013-12-31 | $172.74M | 6.48% |
| 2013-09-30 | $162.23M | -1.20% |
| 2013-06-30 | $164.20M | 0.93% |
| 2013-03-31 | $162.69M | -0.90% |
| 2012-12-31 | $164.16M | 1.27% |
| 2012-09-30 | $162.10M | 6.79% |
| 2009-12-31 | $151.80M | 11.37% |
| 2009-09-30 | $136.30M | -2.01% |
| 2009-06-30 | $139.10M | 7.83% |
| 2009-03-31 | $129.00M | 1.02% |
| 2008-12-31 | $127.70M | -6.24% |
| 2008-09-30 | $136.20M | -4.95% |
| 2008-06-30 | $143.30M | 8.23% |
| 2008-03-31 | $132.40M | 7.47% |
| 2007-12-31 | $123.20M | 9.41% |
| 2007-09-30 | $112.60M | -8.31% |
| 2007-06-30 | $122.80M | 13.28% |
| 2007-03-31 | $108.40M | -7.35% |
| 2006-12-31 | $117.00M | 11.64% |
| 2006-09-30 | $104.80M | -0.38% |
| 2006-06-30 | $105.20M | 4.26% |
| 2006-03-31 | $100.90M | 1.20% |
| 2005-12-31 | $99.70M | 7.67% |
| 2005-09-30 | $92.60M | - |
Phibro Animal Health generated $263.22M in revenue during Q3 2024, up 5.31% compared to the previous quarter, and up 107.59% compared to the same period a year ago.
Phibro Animal Health Revenue Breakdown
Phibro Animal Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|---|
| Vaccines | $120.85M | $100.00M | $88.32M | - | - |
| Animal Health | - | - | - | $72.94M | $75.34M |
| Mineral Nutrition | - | - | - | $220.56M | $214.41M |
| Performance Products | - | - | - | $67.07M | $59.04M |
Phibro Animal Health's latest annual revenue breakdown by segment (product or service), as of Jun 24: Vaccines (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vaccines | $31.99M | $32.92M | $29.73M | $26.22M | $26.20M | $22.77M | $23.02M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Mineral Nutrition | - | - | - | - | $58.44M | $62.92M | $61.64M | $59.65M | $69.03M | $66.66M | $54.43M | $56.81M | $58.15M | $54.16M | $51.44M | $49.88M | $56.20M | $55.69M | $52.65M | $60.65M |
| Performance Products | - | - | - | - | $19.85M | $18.32M | $19.20M | $18.02M | $22.00M | $15.13M | $19.23M | $16.74M | $19.20M | $15.75M | $15.38M | $13.61M | $15.56M | $14.64M | $15.22M | $15.89M |
| Animal Health | - | - | - | - | $176.75M | $164.43M | $163.80M | $154.86M | $22.86M | $21.87M | $21.25M | $18.73M | $18.87M | $18.27M | $17.07M | $18.62M | $21.67M | $18.67M | $16.38M | $16.87M |
Phibro Animal Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Vaccines (100.00%).
Phibro Animal Health Revenue Breakdown by Country
Annual Revenue by Country
| Country | Jun 24 | Jun 23 | Jun 22 | Jun 21 | Jun 20 |
|---|---|---|---|---|---|
| Asia Pacific | $63.23M | $61.45M | $66.93M | $58.01M | $57.30M |
| UNITED STATES | $584.76M | $578.77M | $561.80M | - | - |
| Latin America and Canada | $247.71M | $219.85M | $191.05M | - | - |
| EMEA | $121.98M | $117.81M | $122.48M | - | - |
| Vaccines | - | - | $88.32M | - | - |
| Latin America And Canada | - | - | - | $166.32M | $158.94M |
| Europe Middle East And Africa | - | - | - | $114.13M | $112.18M |
| U | - | - | - | $494.89M | $471.94M |
Phibro Animal Health's latest annual revenue breakdown by geography, as of Jun 24: UNITED STATES (57.46%), Latin America and Canada (24.34%), EMEA (11.99%), and Asia Pacific (6.21%).
Quarterly Revenue by Country
| Country | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $153.68M | $159.31M | $140.48M | $131.29M | $145.05M | $148.53M | $149.39M | $135.80M | $122.86M | - | - | - | - | - | - | - | - | - | - | - |
| Latin America and Canada | $70.17M | $53.65M | $65.18M | $58.70M | $59.90M | $53.88M | $53.82M | $52.25M | $45.05M | $48.01M | $42.66M | - | - | - | - | - | - | - | - | - |
| EMEA | $32.41M | $33.17M | $29.52M | $26.88M | $32.30M | $28.17M | $27.83M | $29.52M | - | - | - | - | - | - | - | - | - | - | - | - |
| Asia Pacific | $16.91M | $17.08M | $14.76M | $14.48M | $17.80M | $15.09M | $13.61M | $14.95M | $17.82M | $15.53M | $14.75M | $16.15M | $17.17M | $12.89M | $11.79M | $14.10M | $11.67M | $20.73M | $10.80M | $24.35M |
| Vaccines | - | - | - | - | - | $26.20M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Performance Products | - | - | - | - | - | $18.32M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Mineral Nutrition | - | - | - | - | - | $62.92M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Animal Health | - | - | - | - | - | $164.43M | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Europe, Middle East and Africa | - | - | - | - | - | - | - | - | $29.93M | $30.03M | $30.93M | - | - | - | - | - | - | - | - | - |
| United States | - | - | - | - | - | - | - | - | $146.82M | $139.15M | $126.32M | - | - | - | - | - | - | - | - | - |
| Europe Middle East And Africa | - | - | - | - | - | - | - | - | - | - | - | $29.17M | $27.80M | $30.29M | $26.87M | $28.87M | $31.96M | $27.66M | $23.69M | $27.30M |
| Latin America And Canada | - | - | - | - | - | - | - | - | - | - | - | $50.52M | $37.39M | $40.66M | $37.76M | $39.21M | $40.28M | $42.70M | $36.74M | $31.23M |
| U | - | - | - | - | - | - | - | - | - | - | - | $124.44M | $129.37M | $122.31M | $118.77M | $103.71M | $126.83M | $122.92M | $118.49M | - |
Phibro Animal Health's latest quarterly revenue breakdown by geography, as of Jun 24: UNITED STATES (56.26%), Latin America and Canada (25.69%), EMEA (11.86%), and Asia Pacific (6.19%).
Phibro Animal Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| RDY | Dr. Reddy's Laboratories | $279.16B | - |
| PBH | Prestige Consumer Healthcare | $1.13B | $267.14M |
| PAHC | Phibro Animal Health | $977.89M | $263.22M |
| PCRX | Pacira BioSciences | $674.98M | $178.02M |
| COLL | Collegium Pharmaceutical | $566.77M | $144.92M |
| ANIP | ANI Pharmaceuticals | $486.82M | $138.04M |
| PROC | Procaps Group | $409.92M | $118.41M |
| EGRX | Eagle Pharmaceuticals | $316.61M | $64.65M |
| DCPH | Deciphera Pharmaceuticals | $163.36M | $45.00M |
| SSIC | Silver Spike Investment | $11.72M | $2.76B |
PAHC Revenue FAQ
What is Phibro Animal Health’s yearly revenue?
Phibro Animal Health's yearly revenue for 2023 was $977.89M, representing an increase of 3.78% compared to 2022. The company's yearly revenue for 2022 was $942.3M, representing an increase of 13.07% compared to 2021. PAHC's yearly revenue for 2021 was $833.4M, representing an increase of 4.12% compared to 2020.
What is Phibro Animal Health’s quarterly revenue?
Phibro Animal Health's quarterly revenue for Q3 2024 was $263.22M, a 5.31% increase from the previous quarter (Q2 2024), and a 7.13% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $249.94M, a 8.06% increase from the previous quarter (Q1 2024), and a 2.17% increase year-over-year (Q2 2023). PAHC's quarterly revenue for Q1 2024 was $231.3M, a -9.31% decrease from the previous quarter (Q4 2023), and a -0.53% decrease year-over-year (Q1 2023).
What is Phibro Animal Health’s revenue growth rate?
Phibro Animal Health's revenue growth rate for the last 3 years (2021-2023) was 17.34%, and for the last 5 years (2019-2023) was 18.10%.
What are Phibro Animal Health’s revenue streams?
Phibro Animal Health's revenue streams in n 24 are Vaccines
What is Phibro Animal Health’s main source of revenue?
For the fiscal year ending Jun 24, the largest source of revenue of Phibro Animal Health was Vaccines. This segment made a revenue of $120.85M, representing 100.00% of the company's total revenue.